GemPharmatech Co (SHSE:688046) Total Stockholders Equity : ¥2,113.2 Mil (As of Jun. 2024)

View and export this data going back to 2022. Start your Free Trial

What is GemPharmatech Co Total Stockholders Equity?

GemPharmatech Co's Total Stockholders Equity for the quarter that ended in Jun. 2024 was ¥2,113.2 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. GemPharmatech Co's Book Value per Share for the quarter that ended in Jun. 2024 was ¥5.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. GemPharmatech Co's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.07.

GemPharmatech Co Total Stockholders Equity Historical Data

The historical data trend for GemPharmatech Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GemPharmatech Co Total Stockholders Equity Chart

GemPharmatech Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Stockholders Equity

Get a 7-Day Free Trial

240.47

657.24

785.63

1,977.71

2,124.66

GemPharmatech Co Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
Total Stockholders Equity	Get a 7-Day Free Trial													2,042.97	2,082.89	2,124.66	2,131.23	2,113.20

GemPharmatech Co (SHSE:688046) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

GemPharmatech Co's Book Value per Share for the quarter that ended in Jun. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(2113.2	-	0)	/	410
	=	5.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

GemPharmatech Co's Debt-to-Equity for the quarter that ended in Jun. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(118.93	+	37.382)	/	2113.2
	=	0.07

GemPharmatech Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of GemPharmatech Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

GemPharmatech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GemPharmatech Co Ltd (SHSE:688046) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 12, Xuefu Road, Jiangbei New District, Jiangsu Province, Nanjing, CHN, 210032

Website

https://www.gempharmatech.us

GemPharmatech Co Ltd is a provider of?genetically engineered mouse?models?and services to global preclinical research and development communities. It specializes in developing animal models using cutting edge gene-editing technologies with a large collection of?cKO/KO (conditional knockout/knockout) mice, humanized mice, immunodeficient mice, and germ-free mice.

GemPharmatech Co Headlines

No Headlines